Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021

Plain-English summary AI · claude-haiku-4-5-20251001

• Amends 2013 Act to set specific criteria for orphan medicines when HSE decides whether to add items to the Reimbursement List.
• Orphan medicines treat rare diseases affecting small patient populations; criteria will guide HSE funding decisions for these products.
• Bill is at Committee Stage; specific criteria details not yet finalised in public records provided.

Stage timeline

1. First Stage 33rd Dáil

   5 Oct 2021
2. Second Stage 33rd Dáil

   5 Oct 2021
3. Committee Stage 33rd Dáil

   27 May 2025